Erika Duffell
Biographic Data
| ID | 7783714 |
|---|---|
| NAME | Erika Duffell |
| GIVEN NAMES | Erika |
| FAMILY NAME | Duffell |
| SIGNATURE | DUFFELL E |
| AFFILIATIONS | European Centre for Disease Prevention and Control |
| VERIFIED | No |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 3 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2001 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
BACKGROUND: With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority of new cases, however testing and treatment remain suboptimal. The aim was to monitor progress in HCV policy and cascade-of-care for PWID, led by the civil society organisations (CSO) that provide harm re…
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from t…
Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016–2019)
Background: A robust estimate of the number of people with chronic hepatitis C virus (HCV) infection is essential for an appropriate public health response and for monitoring progress toward the WHO goal of eliminating viral hepatitis. Existing HCV prevalence studies in the European Union (EU)/European Economic Area (EEA) countries are heterogeneous and often of poor quality due to non-probability based sampling methods, small sample sizes and la…
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy to eliminate HCV as public health threat by 2030. To achieve this, key policies for PWID must be implemented and HCV continuum of care needs to be moni…
Hepatitis C virus infection in EU/EEA and United Kingdom prisons
HCV burden in prisons remains high, amidst suboptimal levels of interventions. Systematic monitoring at both local and regional levels is warranted, to advance progress towards the elimination of HCV in the region
Adverse pregnancy outcomes around incinerators and crematoriums
Dummer and colleagues, research provides an important step towards establishing the evidence base around the adverse pregnancy outcomes associated with incinerators and crematoriums.1 Investigating the possible adverse health effects from environmental hazards is a public health challenge that demands the use of systematic and reproducible research methods. We have some concerns regarding the study described by Dummer and colleagues. The study fo…
Attitudes of parents towards measles and immunisation after a measles outbreak in an anthroposophical community
The introduction of mass immunisation against measles in the United Kingdom has seen the virtual disappearance of this disease. In some European countries with lower levels of vaccine coverage, however, deaths from measles are still common and the disease is associated with significant morbidity.1 In recent years adverse publicity surrounding the vaccine has depressed vaccine uptake in the United Kingdom. Parental attitude towards disease is know…
Attitudes of parents towards measles and immunisation after a measles outbreak in an anthroposophical community
The introduction of mass immunisation against measles in the United Kingdom has seen the virtual disappearance of this disease. In some European countries with lower levels of vaccine coverage, however, deaths from measles are still common and the disease is associated with significant morbidity.1 In recent years adverse publicity surrounding the vaccine has depressed vaccine uptake in the United Kingdom. Parental attitude towards disease is know…
Attitudes of parents towards measles and immunisation after a measles outbreak in an anthroposophical community
The introduction of mass immunisation against measles in the United Kingdom has seen the virtual disappearance of this disease. In some European countries with lower levels of vaccine coverage, however, deaths from measles are still common and the disease is associated with significant morbidity.1 In recent years adverse publicity surrounding the vaccine has depressed vaccine uptake in the United Kingdom. Parental attitude towards disease is know…
Adverse pregnancy outcomes around incinerators and crematoriums
Dummer and colleagues, research provides an important step towards establishing the evidence base around the adverse pregnancy outcomes associated with incinerators and crematoriums.1 Investigating the possible adverse health effects from environmental hazards is a public health challenge that demands the use of systematic and reproducible research methods. We have some concerns regarding the study described by Dummer and colleagues. The study fo…
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy to eliminate HCV as public health threat by 2030. To achieve this, key policies for PWID must be implemented and HCV continuum of care needs to be moni…
Hepatitis C virus infection in EU/EEA and United Kingdom prisons
HCV burden in prisons remains high, amidst suboptimal levels of interventions. Systematic monitoring at both local and regional levels is warranted, to advance progress towards the elimination of HCV in the region
Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016–2019)
Background: A robust estimate of the number of people with chronic hepatitis C virus (HCV) infection is essential for an appropriate public health response and for monitoring progress toward the WHO goal of eliminating viral hepatitis. Existing HCV prevalence studies in the European Union (EU)/European Economic Area (EEA) countries are heterogeneous and often of poor quality due to non-probability based sampling methods, small sample sizes and la…
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from t…
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
BACKGROUND: With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority of new cases, however testing and treatment remain suboptimal. The aim was to monitor progress in HCV policy and cascade-of-care for PWID, led by the civil society organisations (CSO) that provide harm re…
Environmental health (7 works) · Medicine (7 works) · Hepatitis B Virus Studies (5 works) · Hepatitis C virus research (5 works) · Public health (5 works) · Hepatitis C (4 works) · Virology (4 works) · European union (3 works) · Harm (3 works) · Harm reduction (3 works)